68 related articles for article (PubMed ID: 25862079)
21. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
22. Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers.
Kumondai M; Hosono H; Orikasa K; Arai Y; Arai T; Sugimura H; Ozono S; Sugiyama T; Takayama T; Sasaki T; Hirasawa N; Hiratsuka M
Biol Pharm Bull; 2016; 39(1):84-9. PubMed ID: 26725431
[TBL] [Abstract][Full Text] [Related]
23. [Single nucleotide polymorphisms of slow troponin T gene in Han ethnic population from Northern China].
Xu CY; Hu Y; Liu HP
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Nov; 22(4):430-3. PubMed ID: 21155267
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of XRCC1 gene and susceptibility to gastric cancer in Chinese Han population.
Lu Z; Luo T; Nie M; Bi J; Ke C; Xue X; Ma L; Fang G
Biomarkers; 2013 Sep; 18(6):542-6. PubMed ID: 23919819
[TBL] [Abstract][Full Text] [Related]
25. The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations.
Dong Q; Xu B; Tan Y; Liu Z; Tian L; Zhang B; Lin CK; Kung HF; Sung JJ; He ML
Biomed Pharmacother; 2009 Nov; 63(9):658-62. PubMed ID: 18926661
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
Oscarson M; McLellan RA; Asp V; Ledesma M; Bernal Ruiz ML; Sinues B; Rautio A; Ingelman-Sundberg M
Hum Mutat; 2002 Oct; 20(4):275-83. PubMed ID: 12325023
[TBL] [Abstract][Full Text] [Related]
27. [Association of the nicotine and cigarette smoke toxicants metabolic (CHRNA3/5, CYP2A6, NQO1) and DNA repair genes (XRCC1, XRCC3, XPC, XPA) with chronic obstructive pulmonary disease].
Korytina GF; Akhmadishina LZ; Kochetova OV; Burdiuk IuV; Aznabaeva IuG; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2014; 48(6):939-51. PubMed ID: 25845234
[TBL] [Abstract][Full Text] [Related]
28. [Genetic polymorphism of the PRODH and 5-HT(2A) receptor gene in Korean-Chinese and Han nationality in Chinese Yanbian area].
Jiang WK; Xu QS; Piao YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):93-5. PubMed ID: 18247315
[TBL] [Abstract][Full Text] [Related]
29. X-chromosome STRs polymorphisms of Han ethnic group from Northwest China.
Yu B; Zhang H; Li S
Forensic Sci Int; 2005 Oct; 153(2-3):269-71. PubMed ID: 16139117
[TBL] [Abstract][Full Text] [Related]
30. Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations.
Twesigomwe D; Drögemöller BI; Wright GEB; Adebamowo C; Agongo G; Boua PR; Matshaba M; Paximadis M; Ramsay M; Simo G; Simuunza MC; Tiemessen CT; Lombard Z; Hazelhurst S
Clin Pharmacol Ther; 2024 Mar; 115(3):576-594. PubMed ID: 38049200
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphism for the PowerPlex 16 system from the Chinese Tujia Ethnic Minority Group.
Wei H; Zhao Q; Li S
J Forensic Sci; 2006 May; 51(3):709-10. PubMed ID: 16696735
[TBL] [Abstract][Full Text] [Related]
32. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
Yoshida R; Nakajima M; Nishimura K; Tokudome S; Kwon JT; Yokoi T
Clin Pharmacol Ther; 2003 Jul; 74(1):69-76. PubMed ID: 12844137
[TBL] [Abstract][Full Text] [Related]
33. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y
Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352
[TBL] [Abstract][Full Text] [Related]
34. Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese.
Zhang JP; Zhou SF; Chen X; Huang M
Clin Chim Acta; 2006 Mar; 365(1-2):337-41. PubMed ID: 16223474
[TBL] [Abstract][Full Text] [Related]
35. Association of CYP2A6 gene deletion with cancers in Japanese elderly: an autopsy study.
Abudushataer M; Sato N; Mieno M; Sawabe M; Muramatsu M; Arai T
BMC Cancer; 2020 Mar; 20(1):186. PubMed ID: 32131765
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of the drug-metabolizing enzyme cytochrome P450 2A6 in a Tibetan Chinese population.
Xia R; Zhu X; Chen Z; He Y; Kang L; Yuan D; Jin T; Wang L
Int J Clin Exp Pathol; 2018; 11(10):5024-5033. PubMed ID: 31949579
[TBL] [Abstract][Full Text] [Related]
37. Identification of Genetic Polymorphisms of CYP2W1 in the Three Main Chinese Ethnicities: Han, Tibetan, and Uighur.
Li Y; Kang X; Yang G; Dai P; Chen C; Wang H
Drug Metab Dispos; 2016 Sep; 44(9):1510-5. PubMed ID: 27307299
[TBL] [Abstract][Full Text] [Related]
38. Impact of CYP2A6 gene polymorphism on the pharmacokinetics of dexmedetomidine for premedication.
Wang L; Wang S; Qi J; Yu R; Zhuang J; Zhuang B; Lou Y; Ruan J; Ye H; Lin F
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):917-922. PubMed ID: 30092666
[TBL] [Abstract][Full Text] [Related]
39. CYP2E1 gene rs6413420 polymorphism was first found in the Bouyei ethnic group of China.
Liu W; Zhou L; Wang H; Zheng B; Wu D; Yang X; Liu J
Int J Clin Exp Med; 2014; 7(10):3612-20. PubMed ID: 25419409
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.
Jin T; Shi X; Wang L; Wang H; Feng T; Kang L
BMC Genet; 2016 May; 17(1):70. PubMed ID: 27233804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
